Charles Schwab Investment Management Inc. Cuts Stake in U.S. Physical Therapy, Inc. (NYSE:USPH)

Charles Schwab Investment Management Inc. reduced its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 4.0% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 148,901 shares of the company's stock after selling 6,140 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.99% of U.S. Physical Therapy worth $12,601,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in USPH. Canada Pension Plan Investment Board acquired a new position in shares of U.S. Physical Therapy during the second quarter valued at $28,000. Innealta Capital LLC bought a new stake in U.S. Physical Therapy during the second quarter worth approximately $30,000. Quest Partners LLC lifted its holdings in shares of U.S. Physical Therapy by 2,808.3% during the second quarter. Quest Partners LLC now owns 349 shares of the company's stock worth $32,000 after buying an additional 337 shares during the last quarter. Quarry LP raised its position in shares of U.S. Physical Therapy by 1,291.9% during the second quarter. Quarry LP now owns 515 shares of the company's stock valued at $48,000 after buying an additional 478 shares during the last quarter. Finally, Ridgewood Investments LLC acquired a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at $51,000.

Analysts Set New Price Targets

A number of research firms have recently issued reports on USPH. Barrington Research reiterated an "outperform" rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. JPMorgan Chase & Co. upped their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an "overweight" rating in a research report on Tuesday, December 3rd. StockNews.com raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Wednesday, August 21st. Finally, Bank of America reiterated a "neutral" rating and issued a $90.00 price target (down from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th.

U.S. Physical Therapy Trading Up 0.4 %

Shares of NYSE USPH traded up $0.42 during trading on Monday, reaching $96.50. The company had a trading volume of 72,156 shares, compared to its average volume of 93,128. The stock has a market cap of $1.46 billion, a P/E ratio of 102.21, a PEG ratio of 4.34 and a beta of 1.46. The company's fifty day moving average price is $88.04 and its 200-day moving average price is $90.09. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 12 month low of $76.18 and a 12 month high of $113.63.

U.S. Physical Therapy Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 15th were paid a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date of this dividend was Friday, November 15th. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 187.23%.

Insiders Place Their Bets

In related news, insider Eric Joseph Williams sold 2,000 shares of the business's stock in a transaction on Friday, November 8th. The stock was sold at an average price of $95.84, for a total transaction of $191,680.00. Following the sale, the insider now directly owns 14,814 shares in the company, valued at approximately $1,419,773.76. The trade was a 11.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Graham D. Reeve sold 1,724 shares of the firm's stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $96.29, for a total transaction of $166,003.96. Following the completion of the transaction, the chief operating officer now owns 7,106 shares of the company's stock, valued at $684,236.74. This trade represents a 19.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,896 shares of company stock worth $656,940. Corporate insiders own 1.70% of the company's stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.